Produkty 499-29-6

CAS 499-29-6 występuje w naszej ofercie pod nazwami: Coreopsin,Butein–4–O–β–D–glucopyranoside, coreopsin/ 99.47% (existing batch purity), (E)-3-(3,4-Dihydroxyphenyl)-1-(2-hydroxy-4-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)prop-2-en-1-one, Coreopsin, 99.42%. Oferty producentów: GLPBio, TargetMol, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 5mg, 10mg, 25mg, 50mg, 1 mg.

Coreopsin,Butein–4–O–β–D–glucopyranoside
GLPBio
  • opakowanie: 1mg
  • Warianty: 1
od 1345,92
Zobacz produkt
coreopsin/ 99.47% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 5
od 1129,62
Zobacz produkt
(E)-3-(3,4-Dihydroxyphenyl)-1-(2-hydroxy-4-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)prop-2-en-1-one
Chemat
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 5
od 947,60
Zobacz produkt
Coreopsin, 99.42%
MedChemExpress
  • opakowanie: 1 mg
  • Warianty: 1
od 1633,94
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(E)-3-(3,4-dihydroxyphenyl)-1-[2-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-en-1-one (CAS 499-29-6) to związek chemiczny o wzorze sumarycznym C21H22O10 i masie molowej 434.4 g/mol. Nazwa systematyczna IUPAC: (E)-3-(3,4-dihydroxyphenyl)-1-[2-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-en-1-one. InChIKey: QMVODIKHHIRSGI-RWGOFXMDSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H22O10
Masa molowa434.4 g/mol
Nazwa IUPAC(E)-3-(3,4-dihydroxyphenyl)-1-[2-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-en-1-one
InChIKeyQMVODIKHHIRSGI-RWGOFXMDSA-N
SMILESC1=CC(=C(C=C1/C=C/C(=O)C2=C(C=C(C=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: butein 4'-beta-D-glucoside, coreopsin, butein 4'-glucoside, orb1296883
Izomery (ten sam wzór sumaryczny)
(2R,3R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3-dihydrochromen-4-one C21H22O10
(10R)-1,5,8-trihydroxy-3-(hydroxymethyl)-10-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-10H-anthracen-9-one C21H22O10
5-hydroxy-3,7-bis(2-hydroxyethoxy)-2-[3-hydroxy-4-(2-hydroxyethoxy)phenyl]chromen-4-one C21H22O10
(E)-1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one C21H22O10
7-hydroxy-2-(4-hydroxyphenyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one C21H22O10
7-hydroxy-9-methoxy-1-methyl-3-[(2S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzo[c]chromen-6-one C21H22O10
(E)-1-[2,6-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one C21H22O10
(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one C21H22O10
(2R,3S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3-dihydrochromen-4-one C21H22O10
5-hydroxy-2-(3-hydroxy-4,5-dimethoxyphenyl)-3,6,7,8-tetramethoxychromen-4-one C21H22O10
(2R,3R)-3,5-dihydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3-dihydrochromen-4-one C21H22O10
7-hydroxy-2-[3-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydrochromen-4-one C21H22O10